- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07575451
Empowering Families in Pediatric Cardiovascular Surgery: A RAM-Based Approach
Evaluation of a Nursing Program Based on Roy's Adaptation Model for Empowering Families of Children Aged 1 to 3 Years Post-Cardiac Surgery
The purpose of this clinical trial is to learn about the effects of a nursing support program designed for families of children aged 1 to 3 years who have undergone heart surgery. This program aims to improve parents' caregiving skills and support the healthy growth of their children.
The primary questions the study aims to answer are:
Does the nursing program positively affect the physical growth of children, such as their height and weight?
Does the program improve children's scores on general development tests (Denver II)?
Do parents' attitudes toward child feeding and their confidence in parenting skills increase?
Researchers will divide participants into two groups:
Experimental Group: Families who participate in the nursing education program and receive an informative booklet.
Control Group: Families who only receive an informative booklet and continue with routine hospital follow-ups.
The researchers will compare these two groups to see if participating in the nursing program leads to better results for the children's development and the families' skills.
Participants will be asked to:
Attend 5 different education and counseling sessions, starting one week before surgery and continuing until the child reaches 1 year of follow-up.
Meet with the researcher at specific intervals (at 1, 2, 3, 6, 9, and 12 months) for one year to monitor the child's development (height, weight, head circumference) and skills.
Complete surveys regarding child feeding attitudes and parenting skills at the 6th and 12th month follow-ups.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Detailed Description
- Study Rationale and Objectives This study is designed as an experimental research project to evaluate the effectiveness of a nursing empowerment program based on Roy's Adaptation Model (RAM). The primary objective is to empower the families of children aged 1 to 3 years who have undergone cardiovascular surgery and to examine the impact of this empowerment on the children's growth, development, and parental outcomes.
- Study Design and Setting Design: Prospective, randomized controlled experimental trial.Study Sites: Çukurova University Faculty of Medicine Balcalı Hospital and Adana City Training and Research Hospital (Pediatric Cardiovascular Surgery Departments).Timeframe: June 15, 2026 - June 15, 2027.
Participants and Randomization Universe: All families of children aged 1-3 years undergoing heart surgery at the specified hospitals during the study period.
Sample Size: Calculated using G*Power 3.1.9.2 (Effect size $f = 0.25$, $\alpha = 0.05$, power $= 0.80$).Randomization: Participants will be assigned to either the Experimental Group or the Control Group using a simple random number table. Homogeneity between groups will be verified via Chi-square and t-tests regarding baseline demographics (age, education, income).
- Interventions Experimental Group (Empowerment Program):Families will participate in the "RAM-Based Family Empowerment Program."The program consists of 5 structured sessions:Pre-operative (1 week before): Preparation and baseline assessment.Post-operative (First day in ward): Post-op counseling and support.1st Month Follow-up: First follow-up education session.2nd Month Follow-up: Second follow-up education session.3rd Month Follow-up: Final structured education session.Educational materials include a RAM-based booklet, brochures, and visual aids (videos/posters) focusing on physiological, self-concept, role function, and interdependence modes.Control Group:Families will receive routine hospital care.A "RAM-Based Post-Cardiac Surgery Family Empowerment Booklet" will be provided as a baseline resource, but no structured counseling sessions will be conducted.
- Data Collection and Follow-up Schedule All measurements and evaluations throughout the study will be performed face-to-face by the same researcher to ensure data consistency and reliability. The data collection process begins with a Baseline (Pre-operative) assessment conducted one week before surgery, where all tools-including the Sociodemographic and Anthropometric Data Form, the RAM-Based Assessment Form, the Denver II Developmental Screening Test, the Maternal Attitudes Toward Feeding Process Scale (MAFPS), and the Parental Self-Efficacy Scale-are administered to the participants. Following the intervention, a structured follow-up schedule is implemented to monitor the child's physical growth and the family's adaptation process. During the 1st, 2nd, 3rd, and 9th months post-operatively, researchers will perform anthropometric measurements (including height, weight, head circumference, and BMI) and the Denver II test to track developmental progress. At the 6th and 12th-month follow-ups, a comprehensive full assessment will be conducted; this includes a repeat of all anthropometric measurements and the Denver II test, along with the re-administration of the MAFPS for mothers and the Parental Self-Efficacy Scale for both mothers and fathers to evaluate long-term parental outcomes and the sustained effectiveness of the empowerment program.
- Pilot Study A pilot study will be conducted with 10 families to test the clarity of the educational content and the duration of data collection tools. Pilot participants will be excluded from the main study analysis.
- Statistical Analysis Data will be analyzed using IBM SPSS 28.Descriptive Statistics: Mean, standard deviation, frequency, and percentage.Group Comparisons: Independent t-test or Mann-Whitney U test.Pre-Post Comparisons: Paired t-test or Wilcoxon test.Multi-Factorial Analysis: Repeated Measures ANOVA to evaluate the change over time between groups.Significance Level: $p < 0.05$.
- Ethical Considerations Ethical approval has been obtained from the Çukurova University Clinical Research Ethics Committee. Written informed consent will be obtained from all participating families. Confidentiality and anonymity of participant data will be strictly maintained. No physical or psychological risks are anticipated for the participants.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Kübra Türker, PhD Student
- Numero di telefono: +905357416538
- Email: kubrakadah@hotmail.com
Backup dei contatti dello studio
- Nome: Şenay Çetinkaya, Prof. Dr.
- Email: scetinkaya@cu.edu.tr
Luoghi di studio
-
-
Adana
-
Adana, Adana, Turchia (Türkiye), 01330
- Çukurova University
-
Contatto:
- Kübra Türker, PhD
- Numero di telefono: +905357416538
- Email: kubrakadah@hotmail.com
-
Contatto:
- Şenay Çetinkaya, Prof. Dr.
- Numero di telefono: +905353492958
- Email: scetinkaya@cu.edu.tr
-
Investigatore principale:
- Şenay Çetinkaya, Prof. Dr.
-
Adana, Adana, Turchia (Türkiye), 01300
- Adana City Training and Research Hospital
-
Contatto:
- Kübra Türker, PhD Student
- Numero di telefono: +905357416538
- Email: kubrakadah@hotmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Families who agree to participate in the study and sign the informed consent form.
- Families of children aged 1-3 years in the preoperative period who are scheduled to undergo cardiac surgery due to congenital heart disease.
- Families who do not speak or read Turkish but will undergo cardiac surgery due to congenital heart disease will also be included in the study with the assistance of an interpreter.
- Families who are over 18 years of age and have access to a mobile phone or internet at home.
Exclusion Criteria:
- Exclusion criteria include the presence of additional congenital malformations, dysmorphic syndromes, chromosomal or endocrine disorders, severe infection, hypothyroidism, or any similar conditions that could lead to growth and developmental delay in the child, alongside congenital heart disease
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Experimental Group
Families of children aged 1-3 who participate in the RAM-based nursing empowerment program
|
RAM-based nursing empowerment program for families of children (ages 1-3) after heart surgery.
Includes 5 structured sessions focusing on family empowerment, coping mechanisms, and child development.
|
|
Comparatore attivo: Control Group
Families who receive routine care and the informative booklet
|
Families in the control group will receive routine care and an educational booklet titled "Family Empowerment Booklet After Cardiac Surgery Based on Roy Adaptation Model".
The booklet provides information on care processes and coping strategies.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Developmental Screening Test II (Denver II)
Lasso di tempo: At months 1, 2, 3, 6, 9, and 12 after the intervention
|
A performance-based test designed to screen children from birth to 72 months for developmental delays.
It evaluates 125 items across four domains: Personal-social, fine motor-adaptive, language, and gross motor skills.
Results are categorized as Normal, Suspected, or Abnormal based on age-standardized performance.
|
At months 1, 2, 3, 6, 9, and 12 after the intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Parental Self-Efficacy Scale (1-3 Years)
Lasso di tempo: Month 6 and Month 12 post-intervention
|
A 51-item scale measuring parental self-efficacy in seven domains: Emotional Competence, Responsive Sensitivity, Protection, Discipline, Play, Teaching, and Daily Routines/Care.
Scores range from 51 to 255; higher scores indicate stronger parental self-efficacy.
|
Month 6 and Month 12 post-intervention
|
|
Child Growth Parameters (Anthropometric Z-Scores)
Lasso di tempo: At months 1, 2, 3, 6, 9, and 12 after the intervention
|
Growth parameters including height, weight, and Body Mass Index (BMI).
Standardized Z-scores (Standard Deviation Scores - SDS) will be calculated using WHO Anthro software based on Turkish growth percentiles (Neyzi et al., 2008).
Malnutrition is defined as Z-scores below -2 SD.
|
At months 1, 2, 3, 6, 9, and 12 after the intervention
|
|
Feeding Process Maternal Attitude Scale (FPMAS)
Lasso di tempo: Month 6 and Month 12 post-intervention
|
This 27-item, 5-point Likert-type scale measures maternal attitudes during the feeding process.
It includes five sub-dimensions: Negative Mood During Meals, Attitudes Toward Inadequate/Unbalanced Nutrition, Negative Feeding Strategies, Forced Feeding, and Reaction to Others' Opinions.
Total scores range from 27 to 135; higher scores indicate more problematic or negative maternal feeding attitudes.
|
Month 6 and Month 12 post-intervention
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Şenay Çetinkaya, Prof. Dr., Çukurova University
Pubblicazioni e link utili
Pubblicazioni generali
- Demirsoy Horta G, Aksu H, Ozsoy S. Use of Roy's Adaptation Model in women's adaptation to the postpartum period. Ege University Faculty of Nursing Journal (Ege Universitesi Hemsirelik Fakultesi Dergisi). 2017; 33(1):180-190.
- Uzun S. Sister Callista Roy: Adaptation Model. In: Karadag A, Caliskan N, Baykara ZG (eds). Nursing Theories and Models. Istanbul: Akademi Basin ve Yayincilik. 2017: 382-397.
- Elibol F, Magden D, Alpar R. Validity and reliability of the parental self-efficacy scale (1-3 years). Bulletin of Community Medicine (Toplum Hekimligi Bulteni). 2007;26(3):25-31.
- Dilsiz H, Dag I. Feeding Process Maternal Attitude Scale (FPMAS): Development, Validity and Reliability Study. Turk J Pediatr Dis (Turkiye Cocuk Hastaliklari Dergisi). 2020; 14:7-15.
- Yalaz K, Anlar B, Bayoglu B. Denver II developmental screening test "Turkish standardization". Ankara: Developmental Child Neurology Association. 2010; 11-26.
- Alimohammadi N, Maleki B, Shahriari M, Chitsaz A. Effect of a care plan based on Roy adaptation model biological dimension on stroke patients' physiologic adaptation level. Iran J Nurs Midwifery Res. 2015 Mar-Apr;20(2):275-81.
- Goudarzi F, Khadivzadeh T, Ebadi A, Babazadeh R. Women's interdependence after hysterectomy: a qualitative study based on Roy adaptation model. BMC Womens Health. 2022 Feb 13;22(1):40. doi: 10.1186/s12905-022-01615-2.
- Erol Ursavas F, Karayurt O. Effects of a Roy's Adaptation Model-Guided Support Group Intervention on Sexual Adjustment, Body Image, and Perceived Social Support in Women With Breast Cancer. Cancer Nurs. 2021 Nov-Dec 01;44(6):E382-E394. doi: 10.1097/NCC.0000000000000854.
- Neyzi O, Bundak R, Gokcay G, Gunoz H, Furman A, Darendeliler F, Bas F. Reference Values for Weight, Height, Head Circumference, and Body Mass Index in Turkish Children. J Clin Res Pediatr Endocrinol. 2015 Dec;7(4):280-93. doi: 10.4274/jcrpe.2183.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 154-70
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Sviluppo del bambino
-
MedDay Pharmaceuticals SAEurofins OptimedTerminatoVolontari sani | Compromissione epatica della categoria Child Pugh moderataFrancia, Ungheria
-
The Hospital for Sick ChildrenBill and Melinda Gates Foundation; Aga Khan UniversityAttivo, non reclutanteUnder Five Child Health Nutrizione e immunizzazionePakistan
-
RenJi HospitalCompletatoRapporto conta piastrinica/diametro milza | Classificazione Child-PughCina
-
Stanford UniversityNational Cancer Institute (NCI)TerminatoCarcinoma epatocellulare ricorrente | Child-Pugh Classe A | Child-Pugh Classe BStati Uniti, Giappone
-
Boehringer IngelheimNon più disponibileMalattie polmonari, interstiziali (nelle popolazioni pediatriche) | Malattia polmonare interstiziale infantile (chILD)
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsCompletatoChild-Pugh Classe A | Carcinoma epatocellulare in stadio IIIA | Carcinoma epatocellulare in stadio IIIB | Carcinoma epatocellulare in stadio IIIC | Carcinoma epatocellulare in stadio IVA | Carcinoma epatocellulare in stadio IVB | Child-Pugh Classe BStati Uniti
-
Centre Hospitalier Universitaire DijonCompletatoCarcinoma epatocellulare di Child-Pugh AFrancia
-
MindRank AI LtdNon ancora reclutamentoCompromissione Epatica (Lieve e Moderata, Classi A e B di Child-Pugh) | Insufficienza Epatica (ID MeSH: D048550)Cina
-
CatalYm GmbHReclutamentoCarcinoma epatocellulare di Child-Pugh A | Carcinoma epatocellulare non resecabile o metastatico | Fallimento del trattamento di prima linea che includeva un composto anti PD-(L)1 approvatoItalia, Germania
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCCompletatoCarcinoma epatocellulare adulto avanzato | Child-Pugh Classe A | Carcinoma epatocellulare in stadio III | Carcinoma epatocellulare in stadio IIIA | Carcinoma epatocellulare in stadio IIIB | Carcinoma epatocellulare in stadio IIIC | Carcinoma epatocellulare in stadio IV | Carcinoma epatocellulare in... e altre condizioniStati Uniti
Prove cliniche su RAM-based Nursing Empowerment Program
-
University of ManitobaCanadian Institutes of Health Research (CIHR)ReclutamentoViolenza, domesticaCanada
-
University of Southern CaliforniaThe Leona M. and Harry B. Helmsley Charitable TrustCompletatoDiabete mellito di tipo 1Stati Uniti